Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications - PubMed
Review
Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications
Malak El Sabeh et al. Stem Cell Rev Rep. 2021 Jun.
Abstract
Stem cells in the endometrium and myometrium possess an immense regenerative potential which is necessary to maintain the menstrual cycle and support pregnancy. These cells, as well as bone marrow stem cells, have also been implicated in the development of common benign gynecological disorders including leiomyomas, endometriosis and adenomyosis. Current evidence suggests the conversion of uterine stem cells to tumor initiating stem cells in leiomyomas, endometriosis stem cells, and adenomyosis stem cells, acquiring genetic and epigenetic alterations for the progression of each benign condition. In this comprehensive review, we aim to summarize the progress that has been made to characterize the involvement of stem cells in the pathogenesis of benign gynecologic conditions which, despite their enormous burden, are not yet fully understood. We focus on the stem cell characteristics and aberrations that contribute to the development of benign gynecological disorders and the possible clinical implications of what is known so far. Lastly, we discuss the role of uterine stem cells in the setting of regenerative medicine, particularly in the treatment of Asherman syndrome.Graphical abstract.
Keywords: Adenomyosis; Endometriosis; Leiomyoma; Uterine stem cells.
Conflict of interest statement
Conflict of interest
The authors have no conflicts of interest to declare that are relevant to the content of this article.
Figures

Flow chart demonstrating the search strategy and number of articles screened and included in the study.

Myometrial stem cells are essential for normal myometrial development and growth of the uterus during pregnancy. These cells divide to give rise to progenitor cells that subsequently differentiate to mature myometrial cells. In response to genetic mutations, epigenetic aberrations, and chromosomal abnormalities, these cells can undergo tumorigenesis, transforming to leiomyoma stem cells. These stem cells interact with mature myometrial cells through the Wnt/β-catenin pathway to promote proliferation and ECM formation, characteristic of leiomyoma development.

Dysfunctional endometrial stem cells, due to multifactorial factors such as genetic predisposition and hormonal dysregulation, undergo retrograde menstruation reaching ectopic sites. Bone marrow stem cells, recruited by the inflammatory nature of this lesion, can also contribute to the endometriosis cell pool. These cells form ectopic endometrial lesions, acquiring genetic and epigenetic alterations to promote migration, proliferation, invasiveness and adhesion, ultimately resulting in inflammation, angiogenesis and increased growth and the subsequent clinical symptoms characteristic of endometriosis.
Similar articles
-
Adenomyosis pathogenesis: insights from next-generation sequencing.
Bulun SE, Yildiz S, Adli M, Wei JJ. Bulun SE, et al. Hum Reprod Update. 2021 Oct 18;27(6):1086-1097. doi: 10.1093/humupd/dmab017. Hum Reprod Update. 2021. PMID: 34131719 Free PMC article. Review.
-
Endometriosis, leiomyoma and adenomyosis: the risk of gynecologic malignancy.
Verit FF, Yucel O. Verit FF, et al. Asian Pac J Cancer Prev. 2013;14(10):5589-97. doi: 10.7314/apjcp.2013.14.10.5589. Asian Pac J Cancer Prev. 2013. PMID: 24289548 Review.
-
Diagnosing adenomyosis: an integrated clinical and imaging approach.
Chapron C, Vannuccini S, Santulli P, Abrão MS, Carmona F, Fraser IS, Gordts S, Guo SW, Just PA, Noël JC, Pistofidis G, Van den Bosch T, Petraglia F. Chapron C, et al. Hum Reprod Update. 2020 Apr 15;26(3):392-411. doi: 10.1093/humupd/dmz049. Hum Reprod Update. 2020. PMID: 32097456 Review.
-
Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma.
Ono M, Bulun SE, Maruyama T. Ono M, et al. Biol Reprod. 2014 Dec;91(6):149. doi: 10.1095/biolreprod.114.123794. Epub 2014 Nov 5. Biol Reprod. 2014. PMID: 25376230 Free PMC article. Review.
-
Structural and molecular features of the endomyometrium in endometriosis and adenomyosis.
Benagiano G, Brosens I, Habiba M. Benagiano G, et al. Hum Reprod Update. 2014 May-Jun;20(3):386-402. doi: 10.1093/humupd/dmt052. Epub 2013 Oct 18. Hum Reprod Update. 2014. PMID: 24140719 Review.
Cited by
-
Mitranovici MI, Chiorean DM, Moraru L, Moraru R, Caravia L, Tiron AT, Cotoi TC, Toru HS, Cotoi OS. Mitranovici MI, et al. Pharmaceuticals (Basel). 2024 Feb 28;17(3):311. doi: 10.3390/ph17030311. Pharmaceuticals (Basel). 2024. PMID: 38543097 Free PMC article. Review.
-
Penariol LBC, Thomé CH, Tozetti PA, Paier CRK, Buono FO, Peronni KC, Orellana MD, Covas DT, Moraes MEA, Silva WA Jr, Rosa-E-Silva JC, Ferriani RA, Faça VM, Poli-Neto OB, Tiezzi DG, Meola J. Penariol LBC, et al. Int J Mol Sci. 2022 Sep 29;23(19):11515. doi: 10.3390/ijms231911515. Int J Mol Sci. 2022. PMID: 36232817 Free PMC article.
-
Hacimoto SYS, Cressoni ACL, Silva LECMD, Padovan CC, Ferriani RA, Rosa-E-Silva JC, Meola J. Hacimoto SYS, et al. PLoS One. 2024 Jul 30;19(7):e0306657. doi: 10.1371/journal.pone.0306657. eCollection 2024. PLoS One. 2024. PMID: 39078824 Free PMC article.
-
Dysbiosis of vaginal and cervical microbiome is associated with uterine fibroids.
Mao X, Chen H, Peng X, Zhao X, Yu Z, Xu D. Mao X, et al. Front Cell Infect Microbiol. 2023 Sep 6;13:1196823. doi: 10.3389/fcimb.2023.1196823. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37743857 Free PMC article.
-
Chiang YF, Huang KC, Huang TC, Chen HY, Ali M, Al-Hendy A, Huang PS, Hsia SM. Chiang YF, et al. Redox Biol. 2024 Dec;78:103411. doi: 10.1016/j.redox.2024.103411. Epub 2024 Oct 26. Redox Biol. 2024. PMID: 39486360 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical